PAMIPARIB HYDRATE

Details

Stereochemistry	ABSOLUTE
Molecular Formula	2C16H15FN4O.3H2O
Molecular Weight	650.6756
Optical Activity	UNSPECIFIED
Defined Stereocenters	2 / 2
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

O.O.O.C[C@]12CCCN1CC3=NNC(=O)C4=C5C(NC2=C35)=CC(F)=C4.C[C@]67CCCN6CC8=NNC(=O)C9=C%10C(NC7=C8%10)=CC(F)=C9

InChI

InChIKey=DSUDUMUXDPNRBY-WWUGNDHESA-N

InChI=1S/2C16H15FN4O.3H2O/c2*1-16-3-2-4-21(16)7-11-13-12-9(15(22)20-19-11)5-8(17)6-10(12)18-14(13)16;;;/h2*5-6,18H,2-4,7H2,1H3,(H,20,22);3*1H2/t2*16-;;;/m11.../s1

HIDE SMILES / InChI

Molecular Formula	C16H15FN4O
Molecular Weight	298.3149
Charge	0
Count

Stereochemistry	ABSOLUTE
Additional Stereochemistry	No
Defined Stereocenters	1 / 1
E/Z Centers	0
Optical Activity	UNSPECIFIED

Molecular Formula	H2O
Molecular Weight	18.0153
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Poly [ADP-ribose] polymerase-1 23 Target ID: CHEMBL3105 Sources: https://www.beigene.com/science-and-product-portfolio/pipeline/pamiparib \| https://cancerres.aacrjournals.org/content/75/15_Supplement/1653 \| https://patents.google.com/patent/WO2013097225A1	Inhibitor 8297		0.83 nM [IC50]
Poly [ADP-ribose] polymerase 2 16 Target ID: CHEMBL5366 Sources: https://www.beigene.com/science-and-product-portfolio/pipeline/pamiparib \| https://cancerres.aacrjournals.org/content/75/15_Supplement/1653 \| https://patents.google.com/patent/WO2013097225A1	Inhibitor 8297		0.11 nM [IC50]

PubMed

Title	Date	PubMed
Pamiparib in combination with tislelizumab in patients with advanced solid tumours: results from the dose-escalation stage of a multicentre, open-label, phase 1a/b trial.	2019 Sep	31378459

Patents

Substance Class	Chemical Created by `admin` on `Sat Dec 16 11:03:48 UTC 2023` Edited by `admin` on `Sat Dec 16 11:03:48 UTC 2023`
Record UNII	BV047JVV2S
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PAMIPARIB HYDRATE

Common Name

English

BGB-290 HYDRATE

Common Name

English

Code System Code Type Description

FDA UNII

BV047JVV2S

Created by admin on Sat Dec 16 11:03:48 UTC 2023 , Edited by admin on Sat Dec 16 11:03:48 UTC 2023

PRIMARY

CAS

1858211-28-5

Created by admin on Sat Dec 16 11:03:48 UTC 2023 , Edited by admin on Sat Dec 16 11:03:48 UTC 2023

PRIMARY

PUBCHEM

135566123

Created by admin on Sat Dec 16 11:03:48 UTC 2023 , Edited by admin on Sat Dec 16 11:03:48 UTC 2023

PRIMARY

Related Record Type Details


					8375F9S90C

PAMIPARIB

ANHYDROUS->SOLVATE


					8375F9S90C

PAMIPARIB

PARENT -> SALT/SOLVATE

Related Record Type Details


					8375F9S90C

PAMIPARIB

ACTIVE MOIETY